Abstract
Cancer is a very “old” disease, with the earliest recorded descriptions of tumors and their treatment found in Egyptian papyrie dating from 1600 B.C. (125). Nevertheless, little if any insight was brought to bear on the biology of cancer until the 19th century, with Schleiden and Schwann’s discovery of the cellular nature of all organisms (140) and Muller’s formulation of microscopic pathology as the foundation of our understanding of disease (99). Later in the 19th century, Virchow proposed that all cells arise from other cells, and that cancer reflected a constitutional predisposition together with an exciting cause, such as chronic irritation. Virchow also promulgated the notion of metastases (143), although he believed the metastatic process to have a “fluid” rather than a cellular basis. Modern cancer research began with Peyton Rous’ demonstration in 1911 that sarcomas in the Plymouth Rock hen could be transmitted to normal hens by the injection of cell-free filtrates of the original tumor (117), suggesting the existence of identifiable cancer-causing agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams JM et al: C-Myc oncogene driven by immunoglobulin enhancer induces lymphoid malignancy in trans-genic mice. Nature 318:533–5, 1985
Ah FW, Kellems RE, Bertino JR, Schimke RT: Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J Biol Chem 253:1357–70, 1978
Ames RN, Durston WE, Yamasaki E et al: Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA 70:2281–5, 1973
Arcamone F, Cassinelli G, Fantini G et al: Adriamycin. 14 hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius. Biotechnol Biochem 11:1101, 1969
Ballmer-Hofer K, Benjamin T: Modulation of phosphorylation of plasma membrane proteins in polyma virus infected cells by the HR-T gene of polyoma virus (abstract). J Cell Biochem Suppl 8A:253, 1984
Baltimore D: Viral RNA-dependent DNA polymerase. Nature 226:1209–11, 1970
Barbacid M: Oncogenes in human cancers and in chemically induced animal tumors. Prog Med Virol 32:86–100, 1985
Bartlett GI, Kreider JW, Purnell DM: Immunotherapy of cancer in animals: Models or muddles. J Natl Cancer Inst 56:207–10, 1976
Bell E, Marek LF, Levinstone DS et al: Loss of division potential in vitro: Aging or differentiation? Science 202:1158–63, 1978
Berenblum I: The cocarcinogenic action of croton resin. Cancer Res 1:44–9, 1941
Bishop JM: Cancer genes come of age. Cell 32:1018–20, 1983
Bishop JM: Retroviruses and cancer genes. In: Klein G, Weinhouse S (eds) Advances in Cancer Research, vol. 37, New York: Academic Press, pp. 1–32, 1982
Bishop JM, Varmus H: Functions and origins of retroviral transforming genes. In: Weiss R, Teich N, Varmus H, Coffin J (eds). RNA Tumor Viruses. New York: Cold Spring Laboratory, pp. 99–1109, 1982
Bittner JJ: Some possible effects of nursing on mammary gland tumor incidence in mice. Science 84: 162–3, 1936
Boveri T: Zellenstudien VI. Die Entwicklung dispermer Seeigeleier. Ein Beitrag zur Befruchtungslehre und zur Theorie des Kerns. Z Naturwiss 43:1, 1907
Bruce WR, Meeker BE, Valeriote FA: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst 37:233–245, 1966
Brugge JS, Erickson RL: Identification of a transformationspecific antigen induced by an avian sarcoma virus. Nature 269:346–8, 1977
Burkitt D: A sarcoma involving the jaws in African children. Br J Surg 46: 218–23, 1958
Burkitt D, Hutt MSR, Wright DH: The African lymphoma. Preliminary observations on response to therapy. Cancer 18:399–410, 1965
Burchenal JH: Adjuvant therapy-theory, practice, and potential. The James Ewing Lecture. Cancer 37: 46–57, 1976
Burchenal JH, Murphy MI, Ellison RR et al: Clinical evaluation of a new antimetabolite in the treatment of leukemia and allied diseases. Blood 8:964–999, 1953
Burgert EO, Glidewell O: Dactinomycin in Wilms’ tumor. JAMA 199:464–8, 1967
Canellos GP, DeVita VT Jr, Arseneau JC et al: Second malignancies complicating Hodgkin’s disease in remission. Lancet 1:947, 1975
Chermann JC, Barre-Sinoussi F, Montagnier L: A new human retrovirus associated with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. Prog Clin Biol Res 182:329–42, 1985
Coccia P, Sather H, Nesbit M et al: Inter-relationship of initial WBC, age and sex in predicting prognosis in childhood acute lymphoblastic leukemia. Am Soc Hematology Meeting (abstract), 1976
Cohen SN, Chang ACY, Boyer HW et al: Construction of biologically functional plasmids in vitro. Proc Natl Acad Sci USA 70:3240–4, 1973
Cooper GM, Lane M-A, Krontiris TG, Goubin G: Analysis of cellular transforming genes by transfection. In: Klein G (ed) Advances in Viral Oncology, Vol. 1, New York: Raven Press, pp. 243–59, 1982
Danna KJ, Nathans D: Bidirectional replication of simian virus 40 DNA. Proc Natl Acad Sci USA 69:3097–3100, 1972
D’Angio GJ, Evans AE, Breslow N et al: The treatment of Wilms’ tumor — results of the National Wilms’ Tumor Study. Cancer 38:633–46, 1976
Davis WH: The relation of the foreign population to the mortality rates of Boston. Bull Am Acad Med 14:19–54, 1913
DeVita VT, Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, PA: JB Lippincott Company, 1986
DeVita VT, Jr, Serpick A, Carbon PP: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 73:881–95, 1970
Djerassi I, Boyer G, Treat C et al: Management of childhood lymphosarcoma and reticulum cell sarcoma with high dose methotrexate and vitrovorum factor. Proc Am Assoc Cancer Res 9:18 (abstract), 1968
Doll R, Hill AB: Smoking and cancer of the lung. Br Med J 2:739–48, 1950
Donner P, Greiser-Wilke R, Moelling K: Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus. Nature 296:262–6, 1982
Downward J, Yarden Y, Mayes E et al: Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307:521–7, 1984
Dubost M, Gauter P, Maral R et al: Un nouvel antibiotique a proprietes antitumorales. CR Acad Sci Paris 257:1813–20, 1963
Duesberg PH: Retroviral transforming genes in normal cells? Nature 304:219–26, 1983
Dulbecco R: Cell transformation by viruses. Science 166:962–8, 1969
Einhorn LH, Furnas BF, Powell N: Combination chemotherapy of disseminated testicular carcinoma with cis-platinum diammine dichloride (CPDD), vinblastine (VLB) and bleomycin (BLEO) Prod Am Soc Clin Oncol 17:240, 1976
Ellison RR, Glidewell O: Improved survival in adults with acute myelocytic leukemia. Proc Am Assoc Cancer Res 20:161, 1979
Ellison RR, Holland JF, Weil M et al: Arabinosyl cytosine. A useful agent in the treatment of acute leukemia in adults. Blood 32:507–23, 1968
Farber S, D’Angio G, Evans A et al: Clinical studies of actinomycin D with special reference to Wilms’ tumor in children. Ann NY Acad Sci 89:421–5, 1960
Farber S, Diamond LK, Mercer RD et al: Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroylglutamic acid (Aminopterin). N Eng J Med 238:787, 1948
Farber S: The effect of ACTH in acute leukemia in childhood. In: Mote JR (ed) Proc of the First Clinical ACTH Conference New York: Blakiston p. 328, 1950
Foley EJ: Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res 13:835, 1953
Frei E, III, Freireich ET, Gehan E et al: Studies of sequential and combination antimetabolite therapy in acute leukemia, 6-mercaptopurine and methotrexate. Blood 18:431–545, 1961
Freireich EJ, Karon M, Frei E, III: Quadruple combination therapy (VAMP) for acute lymphocytic leukemia of childhood. Proc Am Assoc Cancer Res 5:20, 1964
Forth J, Kahn MC: The transmission of leukemia of mice with a single cell. Am J Cancer 31:276–82, 1937
Galen T: On Anatomical Procedures, the Later Books (Duckworth, WLH, trans). Cambridge: Cambridge University Press. 1962
Gilman A: The initial clinical trial of nitrogen mustard. Am J Surg 105:574–5, 1963
Goldie JH, Coldman AJ: A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727–33, 1979
Gottdiener JS, Mathisen DJ, Borer JS et al: Doxorubin cardiotoxicity: Assessment of the late left ventricular dysfunction by radionuclide cineangiography. Ann Intern Med 94:430–5, 1951
Graham FL, Abrahams PJ, Mulder C et al: Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and Simian virus 40. Cold Spring Harbor Symp Quant Biol 39:637–50, 1974
Gray LH: Oxygenation in radiotherapy. 1. Radiobiological considerations. Br J Radiol 30:403–6, 1957
Groffen J, Heisterkamp N, Stephenson JR et al: C-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia. J Exp Med 158:9–15, 1983
Groopman JE, Hartzband PI, Shulman L et al: Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders. Blood 66(3):742–4, 1985
Grodzicker T, Hopkins N: Origins of contemporary DNA tumor virus research. In: Tooze, J (ed). “DNA Tumor Viruses.” New York: Cold Spring Laboratory, pp. 1–61, 1981
Gros P, Croop J, Roninson I et al: Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells. Proc Natl Acad Sci USA 83:337–41, 1986
Gross L: Intradermal immunization of C311 mice against a sarcoma that originated in an animal of the same line. Cancer Res 3:326–33, 1943
Haddow A, Sexton WA: Influence of carbamic esters (urethanes) on experimental animal tumors. Nature 157:500–03, 1946
Haenszel W: Cancer mortality among the foreign-born in the United States. J Natl Cancer Inst 26:37–132, 1961
Halsted WS: Surgical Papers. Baltimore: Johns Hopkins, 1924
Hayflick L, Moorehead P: The serial cultivation of human diploid cell strains. In: Pollack, R (ed), Readings in Mammalian Cell Culture. New York: Cold Spring Laboratory, pp. 27–64, 1981
Hayward WS, Neel B, Astrin S: Activation of a cellular one gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290:475–80, 1981
Hellstrom I, Hellstrom KE, Evans CA et al: Serum mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci USA 62:362–8, 1969
Hellstrom L, Hellstrom KF, Sjogren HO et al: Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumour immunity. Int J Cancer 8:185–91. 1971
Herberman RB. Natural cell-mediated cytotoxicity in male mice. In: Fogh J; Giovanella BC (eds). The Nude Mouse in Experimental and Clinical Research. New York: Academic Press, pp. 135–66, 1978
Herbst AL, Code P, Colton T et al; Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol 125:43–50. 1977
Hertz R, Lewis J, Lipsett MB: Five Years experience with the chemotherapy of metastatic trophoblastic diseases in women. Am J Obstet Gynecol 86:805–14. 1963
Hibbs JB, Jr, Lambert LH, Jr, Remington JS: Possible role of macrophage mediated nonspecific cytotoxicityrin tumour resistance. Nature New Biol 235:45–50, 1972
Hill JM, Roberts J, Loch E et al: L-asparaginase therapy for leukemia and other malignant neoplasms. JAMA 202:882–8. 1967
Hitchings GH, Elion GB: The chemistry and biochemistry of purine analogs. Ann NY Acad Sci 60:195–9, 1954
Hoffman-Falk H, Einat P, Shilo B-Z: Drosophila melanogaster DNA clones homologous to vertebrate oncogenes: Evidence for a common ancestor to the sre and abl cellular genes. Cell 32; 589–98, 1983
Howard A, Pele SR: Synthesis of deoxyribonucleic acid and nuclear incorporation of S/35 as shown by autoradiographs. In: Wolstenholme GFW (ed). Isotopes in Biochemistry. London: Churchill, pp. 138+, 1951
Huebner RJ, Todaro GI: Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci USA 64:1087–94, 1969
Huggins C, Hodges CV: Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate. Cancer Res 1:293–7, 1941
Hunter T, Sefton BM: The transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci USA 77:1311–15, 1980
Kaplan HS: Fundamental mechanisms in combined modality therapy of cancer. Janeway lecture, 1977. Am J Roentgenol 129:383–93, 1977
Karon MR, Freireich EJ, Frei F, III: A preliminary report on vincristine sulfate a new agent for the treatment of acute leukemia. Pediatrics 30:791–6, 1962
Kirsch IB, Morton C, Korsmeyer S et al: Translocations that highlight chromosomal regions of differentiated activity. J Cell Biochem Suppl 8A:88 (abstract), 1984
Klein G: Specific chromosomal translocations and the genesis of B-cell derived tumors in mice and men. Cell 32:311–5. 1983
Klein G: Tumor antigens. Ann Rev Microbiol 20:223–52, 1966
Kontiris TG: The emerging genetics of human cancer. New Engl J Med 309:404–09, 1983
Land H, Parada LF, Weinberg RA: Cellular oncogenes and multistep carcinogenesis. Science 22:771–78, 1983
Land H, Parada LF, Weinberg RA: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596–602, 1983
Levine AS: Cancer in the Young. Masson Publishing, Inc. USA, 767 pp, 1982
Levine AS: Fruit flies, yeasts and one genes: Developmental biology and cancer research come together. Med Ped Oncol 12:357–74, 1984
Levine AS: Viruses, immune dysregulation, and oncogenesis: inferences regarding the cause and evolution of AIDS. In: AIDS: The Epidemic of Kaposi’s Sarcoma and Opportunistic Infections. Friedman-Kien, AE; LJ Laubenstein (eds). Masson Publishing, Inc. USA, pp. 7–21, 1984
Levine AS, Cook JL, Patch CT et al: Adenovirus 2 early gene expression suppresses the tumorigenicity of hybrids formed between hamster cells transformed by adenovirus 2 and simian virus 40. In: Bishop, JM; Graves, M; Rowley, JD (eds) Genes and Cancer. New York: A.R. Liss, pp. 621–38, 1984
Li MC, Hertz R, Spencer DH: Effect of methotrexate upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med 93:361–6, 1956
Luria SF, Delbruck M: Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491–511. 1943
Lynch K, Smith W: Pulmonary asbestosis in carcinoma of the lung in asbesto-silicosis. Am J Cancer 24:56–64, 1935
Mendelsohn MI: Autoradiographic analysis of cell proliferation in spontaneous breast cancer of c3H mouse III. The growth fraction. J Natl Cancer Inst 28:1015–29, 1962
Miller JA: Carcinogenesis by chemicals: An overview GHA Clowes Memorial Lecture. Cancer Res 30:559–76, 1970
Miller RW: The discovery of human teratogens, carcinogens and mutagens. Lessons for the future. In: Hollaender A, deSerres RJ (eds) Chemical Mutagens, vol. 5. New York: Plenum, 1978
Milstein C, Kohler G: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–7, 1975
Mitchison NA, Kinlen IJ: Present concepts in immune surveillance, in; Fougereau, M; Daussel, J (eds) Progress in Immunology 1980. London: Academic Press, pp. 641–50, 1980
Muller J: Classics in oncology. CA 21:305–12, 1971
Muller R, Slamon DJ, Tremblay JM et al: Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature 299:640–4, 1982
Murphree Al, Benedict WF: Retinoblastoma: Clues to human oncogenesis. Science 223:1028–33, 1984
Nebert DW: Genetic differences in susceptibility to chemically induced myelotoxicity and leukemia. Environ Health Prospect 39:11–22. 1981
Nebert DW, Gonzalez FJ: Cytochrome P-450 gene expression and regulation. Trends in Pharmacol Sci 6:160–4, 1985
Newbold R, Overell RW: Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature 304:648–51, 1983
Norton L, Simon R: Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep 61:1307–17, 1977
Nowell PC, Hungerford DA: A unique chromosome in granulocytic leukemia. Science 132:1492, 1960
Penrose LS, Mackenzie HJ, Korn MN: A genetical study of mammary cancer. Br J Cancer 2:168–76, 1948
Pincus MR, van Renswoude J, Harford JB et al: Prediction of the three-dimensional structure of the transforming region of the human bladder oncogene product and its normal cellular homologue. Proc Natl Acad Sci USA 80:5253–5257, 1983
Pinkel D: Five-year follow-up of “total therapy” of childhood lymphocytic leukemia. JAMA 216:648–52, 1971
Powers S, Kataoka T, Fasano O et al: Genes in S. cerevisiae encoding proteins with domains homologous to the mammalian ras proteins. Cell 36:607–12, 1984
Prehn RT: Immunological surveillance: Pro and con. In: Bach, FH; Good, RA (eds) Clinical Immunobiology, vol. 2. New York: Academic Press, pp. 191–203, 1974
Reddy EP, Reynolds RK, Santos E, Barbacid M: A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300:149–52, 1982
Regaud C, Coutard H, Hautant A: Contribution au traitement des cancers endolarynges par les rayons. Tenth Internati Congress of Otolaryngology, pp. 19–22, 1922
Reimer RR, Hoover R, Fraumeni JF, Jr, Young RC: Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med. 297:177, 1977
Rosenberg B, Van Camp I, Krigas T: Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205:698–9, 1965
Rosenberg S: Lymphokine-activated killer cells: a new approach to immunotherapy of cancer. JNCI 75(4):595–603, 1985
Rous P: Transmission of a malignant new growth by means of a cell-free filtrate. J Am Med Assoc 50:198, 1911
Rowe WP: Leukemia virus genomes in the chromosomal DNA of the mouse. In: Harvey Lecture Series 71. New York: Academic Press, pp. 173–92, 1976
Ruley HE: Adenovirus early region IA enables viral and cellular transforming genes to transform primary cells in culture. Nature 304:602–6, 1983
Salmon SE, Hamburger AW et al: Quantitation of differential sensitivity of human tumor cells to anticancer agents. New Engl J Med 298:1321–7, 1978
Schrier PI, Bernards R, Vaessen RTMJ et al: Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 305:771–84, 1983
Schultz MD: The supervoltage story. Janeway lecture, 1974. Am J Roentgenol 124:541–59, 1975
Selawry OS, Frei E, III: Prolongation of remission in acute lymphocytic leukemia by alteration in dose, schedule and route of administration of methotrexate. Clin Res 12:231 (abstract), 1964
Sharp PA: Molecular biology of viral oncogenes. Cold Spring Harb Symp Quant Biol 44:1305–22, 1980
Shimkin MB: Contrary to Nature. DHEW Publication No. NIII 76–720. Washington, DC: Government Printing Office, 1977
Shope RF: Infectious papillomatosis of rabbits. J Exp Med 58:607–24, 1933
Simone JV, Verzosa MS et al: Initial features and prognosis in 363 children with acute lymphocytic leukemia. Cancer 36:2099, 1975
Skipper HE: Reasons for success and failure in treatment of murine leukemia with the drugs now employed in treating human leukemias. Cancer Chemotherapy (vol. 1). Ann Arbor, Michigan: University Microfilms Internati, 1978
Slamon DJ, deKernion JB, Verma IM, Cline M J: Expression of cellular oncogenes in human malignancies. Science 224:256–62, 1984
Smith RL: Recorded and expected mortality among the Japanese of the United States and Hawaii, with special reference to cancer. J Natl Cancer Inst 17:459–73, 1956
Sorge LK, Levy BT, Maness PF: pp60/c-src is developmentally regulated in the neural retina. Cell 36:249–57, 1984
Stewart TA, Pattengale PK, Leder P: Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38(3):627–37, 1984
Stocks P, Korn MN: A cooperative study of the habits, home life, dietary and family histories of 450 cancer patients and of an equal number of control patients. Ann Eugen (Lond) 5:237–80, 1933
Storb R, Weiden PL, Sullivan KM et al: Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304:1529–33, 1981
Tan C, Tasaka H, DiMarco A: Clinical studies of daunomycin. Proc Am Assoc Cancer Res 6:64 (abstract), 1965
Taub R, Moulding C, Battey J et al: Activation and somatic mutation of the translocated c-myc in Burkitt lymphoma cells. Cell 36:339–48, 1984
Temin HM, Mizutani S: RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226:1211–13, 1970
Terman DS, Young JB, Shearer WT et al: Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A. N Engl J Med 305:1195–99, 1981
Thomas L: The lives of a cell. New York: Viking, 1974
Triolo VA: Nineteenth century foundations of cancer research: Advances in tumor pathology, nomenclature, and theories of oncogenesis. Cancer Res 25:75–106, 1965
Varmus HE: Form and function of retroviral proviruses. Science 216:812, 1982
Waterfield MD, Scarce FT, Whittle N et al: Platelet-derived growth factor is structurally related to the putative transforming protein P28/sis of simian sarcoma virus. Nature 304:35–9, 1983
Wilder RJ: The historical development of the concept of metastasis. J Mt Sinai Hosp 23:729–34, 1956
Wong-Staal F, Ratner L, Shaw G et al: Molecular biology of human T-lymphotropic retroviruses. Cancer Res 45(9 Suppl):4539s–44s, 1985
Yunis JJ: The chromosomal basis of human neoplasia. Science 221:227–365, 1983
Zeigler JL, Magrath IT, Olweny CLM: Long survival of Burkitt’s Lymphoma in Uganda. Proc Am Soc Clin Oncol 20:430 (abstract), 1979
Zeller, P, Gutmann II., Hegedus B et al: Methylhydrazine derivatives, a new class of cytotoxic agents. Experientia 19:129, 1963
Zubrod CG, Schepartz S, Leiter J et al: The chemotherapy program of the National Cancer Institute. History, analysis and plans. Cancer Chemother Rep 50:349–540, 1966
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Levine, A.S. (1989). The Biology of Human Cancer, and the Development of a Rational Basis for Treatment. In: Goldfarb, R.H. (eds) Fundamental Aspects of Cancer. Cancer Growth and Progression, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1089-8_1
Download citation
DOI: https://doi.org/10.1007/978-94-009-1089-8_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6980-9
Online ISBN: 978-94-009-1089-8
eBook Packages: Springer Book Archive